U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...
Researchers create a cannabis-derived compound that relieves pain without the risk of addiction or mind-altering effects.
In a new step forward on the quest for better painkillers, scientists have developed a synthetic cannabinoid that keeps the ...
Evidence is stacking up about the influence of cannabinoids on cardiovascular disease, and newer, synthetic options are ...
A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating ...
They bind to a receptor, called cannabinoid receptor one (CB1), on the surface of brain cells and on pain-sensing nerve cells ...
This achievement leverages the pain-relieving properties of cannabis without inducing mind-altering side effects. The ...
Study of CB1 receptor has implications for chronic pain treatment.WhatA research team funded by the National Institutes of ...
whether signalling bias could be the key to accessing pain relief without adverse effects. Although the CB1 receptor is structurally similar to the µ-opioid receptor because they are both GPCRs ...
"This drug has significant implications for chronic pain treatment via peripheral CB1 activation but also could revolutionize the design of drugs targeting other [pain receptors]." The other ...